Euro2K - Cohort of Cihldren with Second Cancer: Long-Term Iatrogenic Effects from Treatment

Head :
De Vathaire Florent

Last update : 08/06/2015 | Version : 3 | ID : 6502

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Cohort of Cihldren with Second Cancer: Long-Term Iatrogenic Effects from Treatment
Sign or acronym Euro2K
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL authorisation request: No. 902287
General Aspects
Medical area Cancer research
Health determinants Addictions
Iatrogenic
Occupation
Keywords solid cancer, radiotherapy, iatrogenic effect, dosimetry, social outcome, second cancer, child
Scientific investigator(s) (Contact)
Name of the director De Vathaire
Surname Florent
Address B2M - 114 rue Edouard Vaillant - 94805 Villejuif
Phone + 33 (0)1 42 11 54 57
Email florent.devathaire@gustaveroussy.fr
Organization Institut National de la Santé et de la Recherche
Collaborations
Funding
Funding status Mixed
Details Wyeth Foundation, INSERM, IReSP.
Governance of the database
Sponsor(s) or organisation(s) responsible Institut National de la Santé et de la Recherche Médicale
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Solid cancer treatment cases for children under 15 years of age are recorded by consulting archives from 8 French and English healthcare institutions.
Database objective
Main objective To quantify the long-term iatrogenic effects of childhood cancer treatment.
Inclusion criteria - Children/adolescents under 15 years old at time of diagnosis;
- Treated for solid cancer in 8 healthcare institutions in France and England;
- Diagnosed with solid cancer before 1986.
Population type
Age Newborns (birth to 28 days)
Infant (28 days to 2 years)
Early childhood (2 to 5 years)
Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Population covered Sick population
Gender Male
Woman
Geography area International
Detail of the geography area - Great Britain (3 hospitals in London) - France (5 cancer treatment centres: Gustave Roussy, Curie Institute in Paris, Jean Godinot Institute in Reims, Claudius Régaud Institute in Toulouse, Antoine Lacassagne Centre in Nice).
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 1985
Date of last collection (YYYY or MM/YYYY) 2012
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 4,500
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Biological data
Administrative data
Clinical data (detail) Direct physical measures
Details of collected clinical data Medical records from cancer treatment centres, medical data collected from individuals/healthcare professionals.
Declarative data (detail) Paper self-questionnaire
Details of collected declarative data The questionnaire is completed by subjects providing information on occupation, social status, integration, family and professional networks, housing, access to bank loans, fertility, offspring, medical problems, access to healthcare, treatment, treatment plan and continuation between childhood and adulthood.
Biological data (detail) Biological analysis results (e.g., anatomopathological report).
Administrative data (detail) Personal identification data (civil status, gender, date of birth, place of birth) collected indirectly from different administrative medical data source and directly from subjects in the study.
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Health care consumption and services
Quality of life/health perception
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Medicines consumption
Procedures
Data collection method The cohort was created between 1985 and 1995 from medical records in 8 centres. An estimation of ionising radiation dosage to all organs inside or outside radiotherapy was conducted between 1992 and 1997. A secondary cancer study was begun in 1995 from single monitoring collected in medical records.
Participant monitoring Yes
Details on monitoring of participants Morbidity and mortality are monitored regularly for the entire cohort by cross-referencing administrative medical sources. Follow-up is also carried out by self-administered questionnaire.
Links to administrative sources Yes
Linked administrative sources (detail) French National Directory of Individuals - RNIPP INSEE and CépiDc INSERM, postal service.
Promotion and access
Promotion
Link to the document http://tinyurl.com/Publis-HAL-FCCSS-EURO2K
Description List of publications in HAL
Link to the document http://tinyurl.com/Pubmed-FCCSS-EURO2K
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) The use of anonymised data is possible for all research teams with recognised experience in the specialist field. Usage is decided on a case-by-case basis and regulated by agreement.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here